학술논문

CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer
Document Type
Article
Source
In: Annals of oncology : official journal of the European Society for Medical Oncology. (Annals of oncology : official journal of the European Society for Medical Oncology, 1 October 2018, 29:viii720)
Subject
Language
English
ISSN
15698041